ImmunityBio, Inc. (IBRX) earnings date

Nasdaq · Mid cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 38 days, typically, give or take 10 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Mon, Nov 9, 2026before open 40 8-K
Q2 FY2026Tue, Aug 4, 2026before open 35 8-K
Q1 FY2026Thu, May 7, 2026before open 37 8-K
Q4 FY2025Mon, Feb 23, 2026before open 54 8-K
Q3 FY2025Tue, Nov 4, 2025after close 35 8-K
Q2 FY2025Tue, Aug 5, 2025before open 36 8-K
Q1 FY2025Mon, May 12, 2025before open 42 8-K
Q4 FY2024Mon, Mar 3, 2025before open 62 8-K

What they guided beta

Q3 FY2026 "BCG Naïve Primary Endpoint Met: In November 2026, we reported that the primary endpoint for Cohort A was met in the randomized QUILT-2.005 trial, and we remain on track to submit an sBLA to the FDA in the fourth quarter of 2026 for ANKTIVA in combination with BCG in patients with BCG-naïve NMIBC." exhibit
Q3 FY2026 "These changes were partially offset by an increase in interest and investment income combined with a decrease in interest expense due to a lower related-party convertible note balance after a partial loan conversion in Q1 2026." exhibit
Q3 FY2026 "These changes were partially offset by an increase in interest and investment income associated with higher treasury securities holdings combined with a decrease in interest expense due to a lower related-party convertible note balance after a partial loan conversion in Q1 2026." exhibit
Q2 FY2026 "Continued advancement across the clinical pipeline, with multiple anticipated regulatory, clinical, and data milestones expected over the next 12 months, including a planned 2026 sBLA submission for the Phase 2B QUILT-2.005 trial in BCG-naïve NMIBC carcinoma in situ (with or without papillary disease)" exhibit
Q2 FY2026 "These changes were partially offset by an increase in interest and investment income combined with a decrease in interest expense due to lower Term SOFR rates and a lower related-party convertible note balance after a partial loan conversion in Q1 2026." exhibit
Q2 FY2026 "These changes were partially offset by an increase in interest and investment income combined with a decrease in interest expense due to lower Term SOFR rates and a lower related-party convertible note balance after a partial loan conversion in Q1 2026." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/IBRX
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/IBRX

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

IBRX earnings date badge

HTML

<a href="https://veritasdata.dev/company/IBRX/"><img src="https://veritasdata.dev/embed/IBRX.svg" alt="IBRX earnings date" width="240" height="56"></a>

Markdown

[![IBRX earnings date](https://veritasdata.dev/embed/IBRX.svg)](https://veritasdata.dev/company/IBRX/)

Script

<script async src="https://veritasdata.dev/embed/IBRX.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/IBRX"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.